Jim is currently Chair at Breye Therapeutics (DK), Rewind Therapeutics (BE), and Spica Therapeutics (BE/DK). Before he was CEO of Karolinska Development, a publicly listed Nordic life science investment fund.
Jim founded bioskills in 2013. bioskills offers strategic advice and hands-on management for entrepreneurs and investors. bioskills translates excellent science into a real business with an attractive investment case for scientists, entrepreneurs and investors.
Jim worked as a Partner at Gimv from 2001 - 2013 focusing on investments in Life Sciences. Prior to joining Gimv in 2001, he was working as a senior scientist at the department of Oncology Drug Discovery at Janssen Pharmaceutica, a Johnson & Johnson company, where he also served on the research management committee of the collaboration with Rigel Pharmaceuticals.
Jim holds BSc and MSc degrees in chemistry and biochemistry from the University of Antwerp and a PhD in molecular and cellular biology from the University of Maastricht.
